scholarly article | Q13442814 |
P50 | author | Julio Licinio | Q15429111 |
Ma-Li Wong | Q32848402 | ||
P2093 | author name string | Gold PW | |
Rothwell NJ | |||
Loddick SA | |||
Bongiorno PB | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | interleukins | Q194908 |
P304 | page(s) | 211-215 | |
P577 | publication date | 1997-05-01 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | Endogenous interleukin-1 receptor antagonist is neuroprotective | |
P478 | volume | 234 |
Q42486284 | Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes |
Q48341086 | Annual review prize lecture cytokines - killers in the brain? |
Q23909485 | Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines? |
Q33884684 | Brain damage in preterm newborns: biological response modification as a strategy to reduce disabilities |
Q35118685 | Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats |
Q35926040 | CNS injury: the role of the cytokine IL-1. |
Q36809420 | Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke |
Q34760173 | Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture |
Q37233036 | Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model. |
Q37115803 | Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis |
Q28190084 | Cytokines and acute neurodegeneration |
Q42473862 | De novo expression of lipocortin-1 in reactive microglia and astrocytes in kainic acid lesioned rat cerebellum |
Q43698304 | Dual effects of interleukin-1beta on N-methyl-D-aspartate-induced retinal neuronal death in rat eyes |
Q44524201 | Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. |
Q34768762 | Extracellular ATP and P2X7 receptors in neurodegeneration |
Q39490897 | Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions? |
Q28363800 | HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death |
Q48475588 | IL-1 beta is released from the host brain following transplantation but does not compromise embryonic dopaminergic neuron survival |
Q48120804 | Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid |
Q41364931 | Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA. |
Q28194382 | Inflammation and infection in clinical stroke |
Q35202804 | Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system. |
Q48807829 | Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice |
Q36202191 | Interleukin-1 and neuronal injury |
Q47573293 | Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations |
Q46610410 | Interleukin-1 receptor antagonist restores homeostatic function and limits multiorgan damage in heatstroke |
Q74746989 | Interleukin-1 receptors: cloning studies and role in central nervous system disorders |
Q37100241 | Interleukin-1beta: a bridge between inflammation and excitotoxicity? |
Q44059878 | Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells |
Q41954356 | Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. |
Q28572894 | Kainic acid induced expression of interleukin-1 receptor antagonist mRNA in the rat brain |
Q35176253 | Knockdown of IL-1β improves hypoxia-ischemia brain associated with IL-6 up-regulation in cell and animal models |
Q33977693 | Multiple molecular penumbras after focal cerebral ischemia |
Q78003712 | Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function |
Q35574583 | Neuromodulatory role of endogenous interleukin-1β in acute seizures: possible contribution of cyclooxygenase-2 |
Q42488438 | Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. |
Q37376007 | Pathways and mechanisms for cytokine signaling of the central nervous system |
Q36901407 | Pharmacogenomics of neuroimmune interactions in human psychiatric disorders |
Q93358519 | Post-stroke inflammation-target or tool for therapy? |
Q33850745 | Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. |
Q44669614 | Proinflammatory Orientation of the Interleukin 1 System and Downstream Induction of Matrix Metalloproteinase 9 in the Pathophysiology of Human Perinatal White Matter Damage |
Q35103371 | Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. |
Q40682652 | Selective increases in cytokine expression in the rat brain in response to striatal injection of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and interleukin-1. |
Q34729401 | Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients |
Q44152183 | Similar time-course of interleukin-1 beta production and extracellular-signal-regulated kinase (ERK) activation in permanent focal brain ischemic injury |
Q48214988 | Temporal profile of expression and cellular localization of inducible nitric oxide synthase, interleukin-1beta and interleukin converting enzyme after cryogenic lesion of the rat parietal cortex |
Q28200818 | The balance between IL-1 and IL-1Ra in disease |
Q35212550 | The effect of progesterone dose on gene expression after traumatic brain injury |
Q33867213 | The meteorology of cytokine storms, and the clinical usefulness of this knowledge |
Q34044609 | The neuroimmune-endocrine axis: pathophysiological implications for the central nervous system cytokines and hypothalamus-pituitary-adrenal hormone dynamics |
Q39794500 | The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications |
Q37095615 | The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective |
Q36508643 | The type 1 interleukin 1 receptor is not required for the death of murine hippocampal dentate granule cells and microglia activation |
Search more.